Literature DB >> 17001468

Glucocorticoid signalling affects pancreatic development through both direct and indirect effects.

E Gesina1, B Blondeau, A Milet, I Le Nin, B Duchene, P Czernichow, R Scharfmann, F Tronche, B Breant.   

Abstract

AIMS/HYPOTHESIS: Beta cell development is sensitive to glucocorticoid levels. Although direct effects of glucocorticoids on pancreatic precursors have been shown to control beta cell mass expansion, indirect effects of these hormones on pancreatic development remain unexplored. This issue was addressed in mice lacking the glucocorticoid receptor (GR) in the whole organism.
MATERIALS AND METHODS: The pancreatic phenotype of GR(null/null) mice was studied at fetal ages (embryonic day [E]) E15.5 and E18 by immunohistochemistry and beta cell fraction measurements. To distinguish between direct and indirect effects, mutant E15.5 fetal pancreata were grafted under the kidney capsule of immunodeficient mice and analysed after 1 week.
RESULTS: E18 GR(null/null) fetuses had smaller digestive tracts and tiny pancreata. Massive pancreatic disorganisation and apoptosis were observed despite the presence of all cell types. E15.5 GR(null/null) mutants were indistinguishable from wild-type regarding pancreatic size, tissue structure and organisation, beta cell fraction and production of exocrine transcription factor Ptf1a, neurogenin 3 and Pdx-1. Grafting E15.5 GR(null/null) pancreata into a GR-expressing environment rescued the increased apoptosis and mature islets were observed, suggesting that GR(null/null) pancreatic cell death can be attributed to indirect effects of glucocorticoids on this tissue. Heterozygous GR(+/null) mutants with reduced GR numbers showed no apoptosis but increased beta cell fraction at E18 and the adult age, strengthening the importance of an accurate GR dosage on beta cell mass expansion. CONCLUSIONS/
INTERPRETATION: Our results provide evidence for GR involvement in pancreatic tissue organisation and survival through indirect effects. GR does not appear necessary for early phases, but its accurate dosage is critical to modulate beta cell mass expansion at later fetal stages, presumably through direct effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17001468      PMCID: PMC1885455          DOI: 10.1007/s00125-006-0449-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  38 in total

1.  Spontaneous resolution of Cushing's syndrome after pregnancy.

Authors:  D C Aron; A M Schnall; L R Sheeler
Journal:  Am J Obstet Gynecol       Date:  1990-02       Impact factor: 8.661

2.  Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years.

Authors:  H O Lithell; P M McKeigue; L Berglund; R Mohsen; U B Lithell; D A Leon
Journal:  BMJ       Date:  1996-02-17

3.  Dissecting the role of glucocorticoids on pancreas development.

Authors:  Emilie Gesina; François Tronche; Pedro Herrera; Belinda Duchene; Willemène Tales; Paul Czernichow; Bernadette Breant
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

4.  Ontogeny of glucocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type-1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development.

Authors:  H J L Speirs; J R Seckl; R W Brown
Journal:  J Endocrinol       Date:  2004-04       Impact factor: 4.286

5.  Glucocorticoids suppress beta-cell development and induce hepatic metaplasia in embryonic pancreas.

Authors:  Chia-Ning Shen; Jonathan R Seckl; Jonathan M W Slack; David Tosh
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

Review 6.  Hormones, brain and stress.

Authors:  E Ronald de Kloet
Journal:  Endocr Regul       Date:  2003-06

7.  Label-retaining cells in the rat pancreas: location and differentiation potential in vitro.

Authors:  Bertrand Duvillié; Myriam Attali; Virginie Aiello; Eric Quemeneur; Raphael Scharfmann
Journal:  Diabetes       Date:  2003-08       Impact factor: 9.461

8.  Aged transgenic mice with increased glucocorticoid sensitivity in pancreatic beta-cells develop diabetes.

Authors:  Behrous Davani; Neil Portwood; Galina Bryzgalova; Martina Kvist Reimer; Thomas Heiden; Claes-Göran Ostenson; Sam Okret; Bo Ahren; Suad Efendic; Akhtar Khan
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

9.  Prenatal exposure to prednisone in humans and animals retards intrauterine growth.

Authors:  J M Reinisch; N G Simon; W G Karow; R Gandelman
Journal:  Science       Date:  1978-10-27       Impact factor: 47.728

10.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

Authors:  Alexandra E Butler; Juliette Janson; Susan Bonner-Weir; Robert Ritzel; Robert A Rizza; Peter C Butler
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

View more
  14 in total

1.  von Hippel-Lindau gene disruption in mouse pancreatic progenitors and its consequences on endocrine differentiation in vivo: importance of HIF1-α and VEGF-A upregulation.

Authors:  Andrea Soggia; Cyrille Ramond; Haruhiko Akiyama; Raphaël Scharfmann; Bertrand Duvillie
Journal:  Diabetologia       Date:  2014-09-04       Impact factor: 10.122

Review 2.  Consequences of a compromised intrauterine environment on islet function.

Authors:  Alice S Green; Paul J Rozance; Sean W Limesand
Journal:  J Endocrinol       Date:  2010-03-11       Impact factor: 4.286

3.  Genetic evidence of the programming of beta cell mass and function by glucocorticoids in mice.

Authors:  B Valtat; C Dupuis; D Zenaty; A Singh-Estivalet; F Tronche; B Bréant; B Blondeau
Journal:  Diabetologia       Date:  2010-09-21       Impact factor: 10.122

4.  Familial glucocorticoid receptor haploinsufficiency by non-sense mediated mRNA decay, adrenal hyperplasia and apparent mineralocorticoid excess.

Authors:  Jérôme Bouligand; Brigitte Delemer; Annie-Claude Hecart; Geri Meduri; Say Viengchareun; Larbi Amazit; Séverine Trabado; Bruno Fève; Anne Guiochon-Mantel; Jacques Young; Marc Lombès
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

5.  Effects of genetics and in utero diet on murine pancreatic development.

Authors:  Chia-Lei Lin; Lyda Williams; Yoshinori Seki; Harpreet Kaur; Kirsten Hartil; Ariana Fiallo; A Scott Glenn; Ellen B Katz; Maureen J Charron; Patricia M Vuguin
Journal:  J Endocrinol       Date:  2014-06-03       Impact factor: 4.286

Review 6.  The regulation of pre- and post-maturational plasticity of mammalian islet cell mass.

Authors:  Teresa Mezza; Rohit N Kulkarni
Journal:  Diabetologia       Date:  2014-05-14       Impact factor: 10.122

Review 7.  Glucocorticoid Signaling in Health and Disease: Insights From Tissue-Specific GR Knockout Mice.

Authors:  Shannon Whirledge; Donald B DeFranco
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

8.  Early metabolic defects in dexamethasone-exposed and undernourished intrauterine growth restricted rats.

Authors:  Emmanuel Somm; Delphine M Vauthay; Audrey Guérardel; Audrey Toulotte; Philippe Cettour-Rose; Philippe Klee; Paolo Meda; Michel L Aubert; Petra S Hüppi; Valérie M Schwitzgebel
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

9.  The stress of starvation: glucocorticoid restraint of beta cell development.

Authors:  L C Matthews; N A Hanley
Journal:  Diabetologia       Date:  2010-11-12       Impact factor: 10.122

10.  Impairment of rat fetal beta-cell development by maternal exposure to dexamethasone during different time-windows.

Authors:  Olivier Dumortier; Nicolas Theys; Marie-Thérèse Ahn; Claude Remacle; Brigitte Reusens
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.